Rational design of chemically controlled antibodies and protein therapeutics
A. Marchand, L. Bonati, S. Shui, L. Scheller, P. Gainza, S. Rosset, S. Georgeon, L. Tang, B. Correia
This study designs and tests small molecule-controlled switchable protein therapeutics by optimizing protein interactions and demonstrating in vitro and in vivo controllability with Venetoclax.
bioRxiv · Dec 22, 2022 · PreprintBioengineering